Stocks Archives - Page 6 of 171 - Money Morning - Only the News You Can Profit From
Profit Alert: ArthroCare (Nasdaq: ARTC) Stock Outshines Broad Market, Climbing 8%
That's because British medical technology company Smith & Nephew PLC will buy ArthroCare in a $1.7 billion all-cash deal, a move aimed at tackling the growing sports medicine industry.To continue reading, please click here...
Stock Market Today: Dow Jones Industrial Average Ends January in the Red
Stock market today, Jan. 31: U.S. stocks closed down Friday, wrapping up a rough January and the worst month in trading in over a year as several corporate earnings weighed on the market.
All three major indices closed in the red. The Dow Jones Industrial Average closed down 0.94%, or 150 points, at 15,699 points. The S&P 500 closed down 0.65%, or 11.6 points, at 1,783 points, and the Nasdaq Composite Index fell 0.47%, or 19 points, to close at 4,104 points.
Energy futures closed down today. Light sweet crude oil for March delivery closed $0.74 to settle at $97.49 per barrel. Heating oil for March delivery closed down 1.0% at $3.00 per gallon, and natural gas lost 1.36%, or $0.07, to close at $4.94 per million BTUs.To continue reading, please click here...
Today’s Stock Market News And Earnings Calendar
Today's stock market news, Jan. 31: U.S. markets rose on Thursday, Facebook Inc. (Nasdaq: FB) reported strong earnings, and fourth-quarter GDP increased 3.2%. The Dow Jones Industrial Average rose 0.7% to 15,848, and the Standard & Poor's 500 Index jumped 1.1% to 1,794. U.S. stock futures were down Friday before the bell after Eurozone inflation levels unexpectedly fell by 0.7%.To continue reading, please click here...
Yahoo (Nasdaq: YHOO) Down 8.7% Today, Is Mayer's Honeymoon Over?
Yahoo (Nasdaq: YHOO) stock has nearly tripled since Chief Executive Officer Marissa Mayer took over in July 2012. But an 8.7% slip today (Wednesday) after a down revenue report has investors wondering whether Mayer's bullish touch is coming to an end.To see the video, please click here...
This Ingenious Company Will Soar, Despite "Analyst" Claim
When it comes to the bioscience sector, the amount of misinformation some so-called "analysts" spread around the blogosphere on any given day is nothing less than breathtaking.
And frankly, I'm not sure whether most of the nonsense comes from ignorance – they just don't understand the science, the regulatory gauntlet, or the doctors who will be prescribing new products.
Or worse – trying to manipulate the market to help out friends holding positions in the stocks they "analyze."But their misinformation can have a very real market impact, and that's why it's so important to point out when it's wrong...
Best Penny Stocks: Why Biotech Keeps Delivering Triple-Digit Gains
The biotech boom that began last year has triggered triple-digit gains in some of the best penny stocks to buy today.
Some of our top penny stocks in biotech recommended last year gained as much as 440%, 231%, and 214%. And the biotech sector is going to keep surging – especially the sector's best low-priced buys.With that in mind, following are three of the best penny stocks in biotech.
Best Stocks to Buy Now: A Money Morning Weekly Recap
Best stocks to buy for the week ending Jan. 24, 2014: Stocks tumbled last week as investors fled global markets amid soft data out of China, and traders dumped crumbling emerging market currencies.To continue reading, please click here...